264
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Aprotinin revisited: formulation, characterization, biodistribution and therapeutic potential of new aprotinin microemulsion in acute pancreatitis

, , , , , , , , , & show all
Pages 525-537 | Received 21 Nov 2014, Accepted 02 Feb 2015, Published online: 04 Mar 2015

References

  • Werle M, Takeuchi H. Chitosan-aprotinin coated liposomes for oral peptide delivery: development, characterization and in vivo evaluation. Int J Pharm 2009;370:26–32
  • Date A, Nagarsenker M. Parenteral microemulsions: overview. Int J Pharm 2008;355:9–30
  • Floyd AG. Top ten considerations in the development of parenteral emulsions. Pharm Sci Technol Today 1999;2:134–43
  • Narang AS, Delmarre D, Gao D. Stable drug encapsulation in micelles and microemulsions. Int J Pharm 2007;345:9–25
  • Talegaonkar S, Azeem A, Ahmad FJ, et al. Microemulsions: a novel approach to enhanced drug delivery. Recent Pat Drug Deliv Formul 2008;2:238–57
  • Bjerregaard S, Andersen LW, Stephens RW, et al. Sustained elevated plasma aprotinin concentration in mice following intraperitoneal injections of w/o emulsions incorporating aprotinin. J Control Release 2001;71:87–98
  • Smith M, Kocher HM, Hunt BJ. Aprotinin in severe acute pancreatitis. Int J Clin Pract 2009;64:84–92
  • Van Acker GJ, Perides G, Steer ML. Co-localization hypothesis: a mechanism for the intrapancreatic activation of digestive enzymes during the early phases of acute pancreatitis. World J Gastroenterol 2006;12:1985–9
  • Steer ML. Early events in acute pancreatitis. Baillieres Best Pract Res Clin Gastroenterol 1999;13:213–25
  • Beger HG, Rau BM. Severe acute pancreatitis: clinical course and management. World J Gastroenterol 2007;13:5043–51
  • Imrie CW, Carter CR, McKay CJ. Acute pancreatitis. In: Garden OJ, ed. Hepatobiliary and pancreatic surgery. Philadelphia: Elsevier Saunders; 2005:249–77
  • Oruc N, Ozutemiz O, Nart D, et al. Inhibition of renin-angiotensin system in experimental acute pancreatitis in rats: a new therapeutic target. Exp Toxicol Pathol 2010;62:353–60
  • Larionova NV, Ponchel G, Duchene D, Larionova NI. Biodegradable cross-linked starch/protein microcapsules containing proteinase inhibitor for oral protein administration. Int J Pharm 1999;189:171–8
  • Kitagawa M, Hayakawa T. Antiproteases in the treatment of acute pancreatitis. J Pancreas 2007;9:518–25
  • Jain J, Fernandes C, Patravale V. Formulation development of parenteral phospholipid-based microemulsion of etoposide. AAPS PharmSciTech 2010;11:826–31
  • Üstündağ-Okur N, Yavaşoğlu A, Karasulu HY. Preparation and evaluation of microemulsion formulations of naproxen for dermal delivery. Chem Pharm Bull 2014;62:135–43
  • Bayrak Y, Iscan M. Phase inversion temperatures of triton X-100/1-butanol/hydrocarbon/water systems. J Surfactants Deterg 2004;7:363–6
  • Üstündağ-Okur N, Apaydın Ş, Karabay-Yavaşoğlu EÜ, et al. Evaluation of skin permeation and anti-inflammatory and analgesic effects of new naproxen microemulsion formulations. Int J Pharm 2011;416:136–44
  • Ganta S, Paxton JW, Baguley BC, Garg S. Pharmacokinetics and pharmacodynamics of chlorambucil delivered in parenteral emulsion. Int J Pharm 2008;360:115–21
  • Lowry OH, Rosgrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265–75
  • Kang BK, Chon SK, Kim SH, et al. Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of anti-tumor activity in vitro and in vivo. Int J Pharm 2004;286:147–56
  • Smyth DR, Tsopelas C. An improved 99mTc- aprotinin kit formulation: quality control analysis of radiotracer stability and cold kit shelf life. Nucl Med Biol 2005;32:885–9
  • Nornoo AO, Osborne DW, Chow DSL. Cremophor-free intraveneous microemulsions for paclitaxel I: formulation, cytotoxicity and hemolysis. Int J Pharm 2008;349:108–16
  • Garcia-Szabo RR, Malik AB. Pancreatitis-induced increase in lung vascular permeability: protective effect of Trasylol. Am Rev Respir Dis 1984;129:580–3
  • Buluç M, Gürdal H, Melli M. Effect of misoprostol and indomethacin on cyclooxygenase induction and eicosanoid production in carrageenan-induced air pouch inflammation in rats. Prostaglandins Other Lipid Mediat 2002;70:227–39
  • Roelofs JJ, Rouschop KM, Leemans JC, et al. Tissue-type plasminogen activator modulates inflammatory responses and renal function in ischemia reperfusion injury. J Am Soc Nephrol 2006;17:131–40
  • Schoenberg MH, Buchler M, Gaspar M, et al. Oxygen free radicals in acute pancreatitis of the rat. Gut 1990;31:1138–43
  • Spormann H, Sokolowski A, Letko G. Effect temporary ischemia upon development and histological patterns of acute pancreatitis in the rat. Pathol Res Pract 1989;184:507–13
  • Jha SK, Dey S, Karki R. Microemulsions – potential carrier for improved drug delivery. Asian J Biomed Pharm Sci 2011;1:5–9
  • Yao J, Wang D, Zhang X, et al. Development of docetaxel self-microemulsifying drug delivery system (SMEDDS) for parenteral delivery: preparation, characterization and in vivo evaluation. Asian J Pharm Sci 2012;7:18–27
  • Ren X, Svirskis D, Alany RG, et al. In-situ phase transition from microemulsion to liquid crystal with the potential of prolonged parenteral drug delivery. Int J Pharm 2012;431:130–7
  • Strickley R. Solubilizing excipients in oral and injectable formulation. Pharm Res 2004;21:201–30
  • Junping W, Takayama K, Nagai T, Maitani Y. Pharmacokinetics and antitumor effects of vincristine carried by microemulsions composed of PEG-lipid, oleic acid, vitamin E and cholesterol. Int J Pharm 2003;251:13–21
  • Cui J, Yu B, Zhao Y, et al. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm 2009;371:148–55
  • Washington C, Davis SS. The production of parenteral feeding emulsions by microfluidizer. Int J Pharm 1988;44:169–76
  • Djordjevic L, Primorac M, Stupar M, Krajisnik D. Characterization of caprylocaproyl macrogolglycerides based microemulsion drug delivery vehicles for an amphiphilic drug. Int J Pharm 2004;271:11–19
  • Peltola S, Saarinen-Savolainen P, Kiesvaara J, et al. Microemulsions for topical delivery of estradiol. Int J Pharm 2003;254:99–107
  • Yue Y, San-Ming L, Li-Min Y, et al. Physicochemical properties and evaluation of microemulsion systems for transdermal delivery of meloxicam. Chem Res Chinese U 2007;23:81–6
  • Warisnoicharoen W, Lansley AB, Lawrence MJ. Nonionic oil-in-water microemulsions: the effect of oil type on phase behavior. Int J Pharm 2000;198:7–27
  • Stranz M, Kastango ES. A review of pH and osmolarity. Int J Pharm Compound 2002;6:216–20
  • Bhatnagara A, Hustinxa R, Alav A. Nuclear imaging methods for non-invasive drug monitoring. Adv Drug Deliv Rev 2000;41:41–54
  • Teran M, Savio E, Paolino A, Frier M. Usage of radiopharmaceuticals in the development of pharmaceutical drug delivery systems: validation of (99mTc)DTPA and (99mTc) ECD. Eur J Pharm Biopharm 2004;57:347–52
  • Burke MD, Staton JS, Viskers AW, et al. A novel method to radiolabel gastric retentive formulations for gamma scintigraphy assessment. Pharm Res 2007;24:695–704
  • Wilding IR, Coupe AJ, Davis SS. The role of gamma scintigraphy in oral drug delivery. Adv Drug Deliv Rev 1991;7:87–117
  • Schaadt BK, Hendel HW, Gimsing P, et al. 99mTc-aprotinin scintigraphy in amliodosis. J Nucl Med 2003;44:177–83
  • Rustom R, Grime S, Maltby P, et al. A new method to measure renal tubular degradation of small filtered proteins in man using radiolabelled aprotinin (Trasylol). Clin Sci 1992;83:289–94
  • Kedar U, Phutane P, Shidhaye S, Kadam V. Advances in polymeric micelles for drug delivery and tumor targeting. Nanomed–Nanotechnol 2010;6:714–29
  • Chen CC, Wang SS, Lee FY. Action of antiproteases on the inflammatory response in acute pancreatitis. J Pancreas 2007;8:488–94
  • Lasson A, Ohlsson K. Protease inhibitors in acute human pancreatitis. Correlation between biochemical changes and clinical course. Scand J Gastroenterol 1984;19:779–86
  • Heinrich S, Schafer M, Rousson V, Clavien PA. Evidence-based treatment of acute pancreatitis: a look at established paradigms. Ann Surg 2006;243:154–68
  • Trapnell JE, Rigby CC, Talbot CH, Duncan EHL. A controlled trial of Trasylol in the treatment of acute pancreatitis. Br J Surg 1974;61:177–82
  • Trapnell JE, Talbot CH, Capper WM. Trasylol in acute pancreatitis. Am J Dig Dis 1967;12:409–12
  • Soleto Saez E, Sanmartin P, Ruiperez S, et al. Treatment of acute pancreatitis by intra-arterial injection of Trasylol. Int Surg 1971;55:299–306
  • Urbánek K, Vinklerová I, Krystyník O, Procházka V. Acute pancreatitis induced by drugs. In: Rodrigo L, ed. Acute pancreatitis. Rijeka, Croatia: In Tech; 2012:17–34

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.